InvestorsHub Logo

Steady_T

10/02/22 6:37 PM

#376102 RE: georgejjl #376090

Thanks George.

WilliamMunny

10/02/22 6:44 PM

#376103 RE: georgejjl #376090

Not sure what the point of this post is. Yes, "All research is embargoed until the date/time that it is available on demand or shared at a CTAD live presentation"...but, if one reads further, one notes that publicly traded companies can request an exemption from CTAD on the embargo if so advised by their legal counsel in order to comply with SEC requirements by releasing certain data. Obviously, Biogen/Eisai must have requested such an exemption (since they are presenting at CTAD) and it was granted. Anavex could do exactly the same thing.